Norway - Hospital Average Length of Stay for Carcinoma in Situ
Since 2014, Norway Hospital Average Length of Stay for Carcinoma in Situ was down by 4.2% year on year. With 2.1 Days in 2019, the country was number 32 among other countries in Hospital Average Length of Stay for Carcinoma in Situ. South Korea topped the ranking with 7.5 Days in 2019, that is a fall of 2.6% versus 2018. Slovakia, Latvia and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +10.6% per year, while New Zealand recorded the worst performance at -8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 2.10 |
| 2018 | 2.40 |
| 2017 | 2.40 |
| 2016 | 2.60 |
| 2015 | 2.70 |
Download all data from 2000 to 2019
How does Norway rank in Hospital Average Length of Stay for Carcinoma in Situ?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
7.50 | 2019 | -2.6 % | +0.8 % | View data | |
| 2 |
#2
Slovakia
|
5.40 | 2019 | +0.0 % | +0.4 % | View data | |
| 29 |
#29
Sweden
|
2.20 | 2019 | -4.3 % | -2.5 % | View data | |
| 32 |
#32
Norway
|
2.10 | 2019 | -12.5 % | -4.2 % | View data | |
| 33 |
#33
Netherlands
|
1.80 | 2019 | -10.0 % | -3.0 % | View data | |